Key points are not available for this paper at this time.
TB-DM patients possess a distinctive plasma lipid profile with pro-atherogenic properties. These findings support further research on the benefits of improved blood lipid control in the treatment of TB-DM.
Vrieling et al. (Thu,) studied this question.